FERRO, ALESSANDRA
 Distribuzione geografica
Continente #
NA - Nord America 377
EU - Europa 78
AS - Asia 19
Totale 474
Nazione #
US - Stati Uniti d'America 377
IT - Italia 35
SE - Svezia 17
CN - Cina 14
FI - Finlandia 9
DE - Germania 7
GB - Regno Unito 6
IN - India 3
CH - Svizzera 2
TR - Turchia 2
IE - Irlanda 1
PL - Polonia 1
Totale 474
Città #
Fairfield 82
Chandler 68
Cambridge 23
Woodbridge 23
Ashburn 21
Houston 21
Padova 17
San Diego 11
Seattle 10
Helsinki 9
Medford 9
Princeton 9
Ann Arbor 8
Des Moines 8
Wilmington 8
Columbus 6
Roxbury 6
Beijing 5
New York 4
Ogden 3
Pune 3
Belluno 2
Duncan 2
Hounslow 2
Pignone 2
Portland 2
Ankara 1
Dublin 1
Guangzhou 1
Gunzenhausen 1
Jolanda di Savoia 1
London 1
Los Angeles 1
Maida Vale 1
Milan 1
New Bedfont 1
Norwalk 1
Santa Clara 1
Seregno 1
Shanghai 1
Torreglia 1
Treviso 1
Washington 1
Zonguldak 1
Totale 382
Nome #
First-Line Osimertinib in Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer: Outcome and Safety in the Real World: FLOWER Study 72
Lung cancer (LC) in HIV positive patients: Pathogenic features and implications for treatment 63
1398P Real-life progression (PD) pattern of EGFR mutant advanced non-small cell lung cancer (aNSCLC) patients (pts) receiving systemic therapy after first- or second-generation tyrosine kinase inhibitor (1-2 gen TKI) 62
149P First-line (1L) osimertinib in EGFR mutant (mut) advanced non-small cell lung cancer (aNSCLC) patients (pts): Progression (PD) pattern and safety in the real-world (RW) 60
Real-world data on treatment outcomes in EGFR-mutant non-small-cell lung cancer patients receiving osimertinib in second or further lines 57
119P The role of circulating markers in predicting immune-related adverse events (irAEs) and their recurrence in advanced non-small cell lung cancer (aNSCLC) patients (pts) 55
Plasma next-generation sequencing (NGS) in advanced non-small cell lung cancer (aNSCLC) patients (pts) treated with immune checkpoint inhibitors (ICIs): Impact of STK11 and TP53 mutations on outcome 47
Clinical Impact of Plasma and Tissue Next-Generation Sequencing in Advanced Non-Small Cell Lung Cancer: A Real-World Experience 42
Subacute Cutaneous Lupus Erythematosus-Like Eruption Induced by EGFR -Tyrosine Kinase Inhibitor in EGFR-Mutated Non-small Cell Lung Cancer: A Case Report 30
Totale 488
Categoria #
all - tutte 2.656
article - articoli 2.656
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.312


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202167 0 0 0 0 0 31 9 2 7 3 1 14
2021/2022225 9 24 41 4 15 35 30 6 8 10 12 31
2022/2023121 23 19 3 17 10 11 1 9 21 4 3 0
2023/202475 11 9 14 7 7 14 5 1 4 3 0 0
Totale 488